Approval · Notice of Compliance 5069 · 1995
IDAMYCIN: Notice of Compliance 5069
Issued May 2, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5069
- Date
- May 2, 1995
- Company
- Pharmacia Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: capsules 5mg, 10mg, 25mg
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IDAMYCIN | 02166100 | Cancelled Post Market |
| IDAMYCIN | Not yet assigned | — |
Medicinal ingredients
- IDARUBICIN HCL 5 MG per CAP
- IDARUBICIN HCL 10 MG per CAP
- IDARUBICIN HCL 25 MG per CAP